Pharma major Dr Reddy’s Laboratories said European Union authorities have again allowed it to produce drugs for sale in the EU region at its Duvvada factory in Andhra Pradesh.
In its inspection conducted in September, the Regulatory Authority of Germany (Regierun von Oberbayern) had made six major observations on the formulations manufacturing facility near Vishakapattanam.
“The products manufactured at the facility are not currently exported to EU,” the company had said at the time. “
The company will be submitting a corrective and preventive action plan (CAPA) to the authorities,” it had added.
Today, it said the EU regulator has permitted production “to start again from this facility for the EU market.”
“.. the CAPA (corrective and preventive action) plan submitted by us has been accepted by the regulator,” it said. “The regulator will reinspect this facility by the end of 2018.”